Marialucia Telesca

University of Campania "Luigi Vanvitelli" — Italy

Medicine · Health Sciences

7h-index240citations39works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(11), Diabetes Treatment and Management(8), Heart Failure Treatment and Management(6), Cardiovascular Disease and Adiposity(5), Cardiac Fibrosis and Remodeling(4)

Publications39 total

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses
Frontiers in Pharmacology·2026Open Access
Additive benefits of dapagliflozin to sacubitril/valsartan in cardiometabolic age-related cardiac dysfunction involve endothelial oxidative defense and senescence
European Heart Journal·2025
Early life stress Induces age-dependent cardiac dysfunction in exposed parents and in their offspring
European Heart Journal·2025
The BET protein inhibitor Apabetalone rescues cardiometabolic heart failure with preserved ejection fraction by suppressing myocardial and systemic inflammation: a study in mice and humans
European Heart Journal·2025
The histone methyltransferase SETD2 promotes lipotoxic injury in cardiometabolic heart failure with preserved ejection fraction
European Heart Journal·2025
Protein misfolding in stroke-heart syndrome: a molecular bridge between brain and heart
European Heart Journal·2025
Nuclear receptor co-repressor 1 promotes macrophage inflammation in heart failure with preserved ejection fraction: a translational study
European Heart Journal·2025
Epigenetic editing of chromatin readers rescues doxorubicin-induced endothelial senescence and vascular dysfunction
European Heart Journal·2025
Investigating the effects of different ratios of Citrus limon, Citrus sinensis, and Vitis vinifera extracts on insulin resistance in HepG2 cells
Journal of Functional Foods·2025Open Access
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension
Cardiovascular Diabetology·2025· 5 citedOpen Access
Chromatin Rewiring by SETD2 Drives Lipotoxic Injury in Cardiometabolic HFpEF
Circulation Research·2025· 10 cited
Abstract 4142848: Apabetalone Protects Against Heart Failure with Preserved Ejection Fraction by Suppressing Myocardial Inflammation
Circulation·2024
AMulti-Beam Forward-Looking Sonar Simulator Based on Unity3D
2024
Targeting BRD4-HK2 reverses the meta-inflammatory shift in perivascular adipose tissue and rescues cardiometabolic vascular dysfunction
European Heart Journal·2024Open Access
Heritable heart failure traits in mice undergoing early life stress
European Heart Journal·2024Open Access
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
European Heart Journal·2024Open Access
Long non-coding RNA PANDA promotes endothelial senescence and oxidative damage through the interaction with NRF2
European Heart Journal·2024· 1 cited
The BET inhibitor Apabetalone protects against heart failure with preserved ejection fraction by suppressing myocardial inflammation
European Heart Journal·2024· 3 cited
The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence
European Heart Journal·2024· 1 citedOpen Access
Effects of sacubitril-valsartan on aging-related cardiac dysfunction
European Journal of Pharmacology·2024· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sarah Costantino(20), Era Gorica(19), Francesco Paneni(17), Konrad Urbanek(15), Donato Cappetta(15), Alessia Mongelli(14), Liberato Berrino(13), Gabriella Bellocchio(9), Antonella De Angelis(9), S A Mohammed(9), Frank Ruschitzka(8), Maria Donniacuo(7), Maria Antonietta Riemma(7), Alessandro Mengozzi(7), Christian M. Matter(7), Frank Ruschitzka(7), Elena Mele(5), Eleonora Cianflone(5), Giuseppe Castaldo(5), Francesco Rossi(5)